Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 14 (Search time: 0.002 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2017
DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironment
Hewett, D.
;
Vandyke, K.
;
Lawrence, D.
;
Friend, N.
;
Noll, J.
;
Geoghegan, J.
;
Croucher, P.
;
Zannettino, A.
2017
HIF-2α promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12/CXCR4 and CCR1
Vandyke, K.
;
Zeissig, M.
;
Hewett, D.
;
Martin, S.
;
Mrozik, K.
;
Cheong, C.
;
Diamond, P.
;
To, L.
;
Gronthos, S.
;
Peet, D.
;
Croucher, P.
;
Zannettino, A.
2017
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress
Wallington-Beddoe, C.
;
Bennett, M.
;
Vandyke, K.
;
Davies, L.
;
Zebol, J.
;
Moretti, P.
;
Pitman, M.
;
Hewett, D.
;
Zannettino, A.
;
Pitson, S.
2015
Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo
Cheong, C.
;
Chow, A.
;
Fitter, S.
;
Hewett, D.
;
Martin, S.
;
Williams, S.
;
To, L.
;
Zannettino, A.
;
Vandyke, K.
2010
The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo
Vandyke, K.
;
Dewar, A.
;
Diamond, P.
;
Fitter, S.
;
Schultz, C.
;
Sims, N.
;
Zannettino, A.
2015
Therapeutic targeting of N-cadherin is an effective treatment for multiple myeloma
Mrozik, K.
;
Cheong, C.
;
Hewett, D.
;
Chow, A.
;
Blaschuk, O.
;
Zannettino, A.
;
Vandyke, K.
2013
Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma
Vandyke, K.
;
Chow, A.
;
Williams, S.
;
To, L.
;
Zannettino, A.
2011
The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation
Vandyke, K.
;
Fitter, S.
;
Zannettino, A.
2010
Dysregulation of bone remodeling by imatinib mesylate
Vandyke, K.
;
Fitter, S.
;
Dewar, A.
;
Hughes, T.
;
Zannettino, A.
2010
Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: A mechanism for improved insulin sensitivity in Type 2 diabetic CML patients?
Fitter, S.
;
Vandyke, K.
;
Schultz, C.
;
White, D.
;
Hughes, T.
;
Zannettino, A.
Discover
Author
6
Fitter, S.
5
Hewett, D.
3
Cheong, C.
3
Chow, A.
3
Croucher, P.
3
Hughes, T.
3
Schultz, C.
3
To, L.
2
Dewar, A.
2
Diamond, P.
.
next >
Subject
5
Humans
3
Benzamides
3
Imatinib Mesylate
3
Leukemia, Myelogenous, Chronic, B...
3
Piperazines
3
Protein Kinase Inhibitors
3
Pyrimidines
2
Absorptiometry, Photon
2
Bone Remodeling
2
Cell Proliferation
.
next >
Date issued
1
2020 - 2023
13
2010 - 2019